|
|
 | | | |
- close
- close
- close
- close
Opexa Therapeutics (OPXA) |
QUOTE AND NEWS
Business Wire
Feb 29
Comment
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has executed an agreement with Pharmaceutical Research Associates, Inc. (PRA)
Business Wire
Jan 17
Comment
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the BOCEMb; Noble Financial
StreetInsider.com
Jun 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Opexa+%28OPXA%29+Meets+with+Health+Canada%27s+BGTD+for+Pre-CTA+for+Tovaxin/6554773.html for the full story.
StreetInsider.com
Apr 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Opexa+%28OPXA%29+Presents+Important+Efficacy+Data+for+Tovaxin/6430553.html for the full story.
Penny Stock DD
Feb 9
Comment
Opexa Therapeutics Inc. (NASDAQ:OPXA) moved down by 18.14% and closed at $1.94 whereas overall traded volume stood at 3.03 million shares for the day. Its outstanding shares stood at 18.47 million and its total market capitalization arrived at...
Penny Stock DD
Jan 6
Comment
Zalicus, Inc. (NASDAQ:ZLCS) surged by 11.67% and closed at $2.01 with overall traded volume of 5.03 million shares in the last trading session. Its price to earnings ratio arrives at 6.93 times till its last trading session. The company is in...
MarketWatch
Jan 5
Comment
Shares of Glaxo are sliding in the wake of a negative report aired by “60 Minutes” while Opexa shares rally on a positive update for its MS drug candidate Tovaxin.
FierceBiotech
Jan 5
Comment
Shares of Opexa Therapeutics shot up more than 60 percent this morning--taking a big gain on a relatively modest step forward on its new MS therapy Tovaxin. The developer says that it successfully completed two discussions with regulators on its...
MarketWatch
Jan 5
Comment
Shares of Opexa Therapeutics soared 65% Wednesday after the biotechnology firm said that it has had two "successful" meetings with Food and Drug Administration officials over development of a drug used to treat multiple sclerosis. The company said...
StreetInsider.com
Jan 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Opexa+Therapeutics+%28OPXA%29+Jumps+On+Positive+FDA+Meetings+on+Tovaxin/6196929.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
